On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
In July 2003, University of Saskatchewan researchers announced they had discovered “follicular waves” in the human menstrual cycle….
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On Jul. 17, 2002, a National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the U.S….
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
On Oct. 17, 2001, the National Center on Birth Defects and Developmental Disabilities (NCBDDD) was established at the…
In 2001, the Regional Cancer Coalitions of Georgia were created by the General Assembly and Governor to ensure…
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
On Jun. 7, 2000, President Clinton issued an Executive Memorandum that directed the Medicare program to revise its…
On Jun. 7, 1999, NeoPath merged with AutoCyte to form TriPath Imaging based in Burlington, N.C. NeoPath was…
On May 25, 1999. the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer…
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
In 1997, the U.S. Centers for Disease Control and Prevention (CDC) convened a group that became the National…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1997, anesthesiologist Joanne Conroy, M.D. became the first woman appointed as head of the University of South…
On Jul. 1, 1996, topotecan (Hycamptin), the first of a class of drugs that interferes with the enzyme…